Elroy Patrick Weledji | Medicine and Dentistry | Research Excellence Award

Prof. Dr. Elroy Patrick Weledji | Medicine and Dentistry | Research Excellence Award

Professor of Surgery | University of Buea | Cameroon

Dr. Elroy Patrick Weledji is a clinician–researcher at the University of Buea, Cameroon, with recognized expertise in general surgery, trauma care, and perioperative management, particularly within resource-limited settings. He has authored 62 peer-reviewed publications, receiving over 792 citations, with an h-index of 14, reflecting sustained scholarly impact. His research spans guideline implementation in colorectal surgery, appendicitis management, complex trauma and orthopedic stabilization, and clinically relevant surgical reviews, with multiple open-access contributions enhancing global knowledge dissemination. Dr. Weledji has collaborated with an extensive international network of more than 180 co-authors, demonstrating strong interdisciplinary and cross-regional engagement. His work emphasizes evidence-based practice, pragmatic surgical solutions, and health system improvement, contributing meaningfully to patient outcomes, surgical education, and the advancement of equitable healthcare delivery in low- and middle-income countries.

Citation Metrics (Scopus)

792
600
400
200
0

Citations

792

Documents

62

h-index

14

Citations

Documents

h-index

View Scopus Profile
View ORCID Profile
View ResearchGate Profile

Featured Publications

Sakarie Mustafe Hidig | Health Professions | Editorial Board Member

Prof. Sakarie Mustafe Hidig | Health Professions | Editorial Board Member

Assistant Professor | Zhejiang University School of Medicine | China

Sakarie Mustafe Hidig is a researcher at Zhejiang University, Hangzhou, China, specializing in biomaterials, drug delivery systems, and immunotherapeutic strategies for cancer treatment. His research focuses on the design of functional polymer-based platforms particularly chitosan hydrogels and boronated diol drug conjugates aimed at enhancing therapeutic efficacy while stimulating robust anti-tumor immune responses. His recent work on a versatile chitosan hydrogel for hepatocellular carcinoma demonstrates a powerful fusion of material science and immune engineering, offering new avenues for more effective and biocompatible cancer therapies. Dr. Hidig has authored 7 peer-reviewed publications, earning 12 citations and maintaining an h-index of 2, reflecting his early but steadily increasing scholarly impact. With collaborations spanning 27 international co-authors, he engages actively in multidisciplinary research that advances innovative, targeted, and safer therapeutic solutions. His contributions address global health priorities by developing responsive materials capable of improving clinical outcomes, reducing toxicity, and shaping the future landscape of cancer treatment technologies.

Profiles: Scopus | ORCID

Featured Publications

1. Hidg, S. M., & Samatar, H. (2025). Optimal timing of percutaneous transhepatic gallbladder drainage in high-risk acute cholecystitis patients and its impact on elective laparoscopic cholecystectomy. RGUHS Journal of Medical Sciences, 15(1), 32–42.

2. Fatima, B., Rubab, N., Mujahid, M. U. F. M., & Hidig, S. M. (2025). A large pediatric retroperitoneal benign lipoma in a 2-year-old female: A case report and literature review. Medicine, December 5, 2025.

3. Hidig, S. M., Mujahid, M. U. F. M., Jie, Y., & Hu, Z. (2025). Status epilepticus and stethoscopes: The struggle and strategy of doctors in the management of status epilepticus in long-term modern warfare conflict settings. Epileptic Disorders, 2025.

4. Yang, S., Zhang, E., Li, Z., Long, Y., Li, Y., Zhang, J., Wang, F., Liu, L., Wang, T., Guo, J., & Hou, Z. (2025). Deep vein thrombosis in patients with patellar fractures: Assessing incidence rates and identifying risk factors. PLOS ONE, 20(2), e0316628.

5. Hidig, S. M., Kakule Kitaghenda, F., & Samatar, H. (2025). Assessing the role of Helicobacter pylori in cholelithiasis development: A meta-analytical approach. Greenfort International Journal of Applied Medical Science, 3(01), Article 004.

Aylin Köseler | Medicine | Best Researcher Award

Prof. Dr. Aylin Köseler | Medicine | Best Researcher Award

Professor | Pamukkale University Medical Faculty | Turkey

Professor Aylin Köseler is a distinguished academic in the field of biophysics and molecular genetics, currently serving in the Department of Biophysics at Pamukkale University Faculty of Medicine. Her extensive research career spans over two decades, focusing on the molecular mechanisms underlying genetic variability, pharmacogenomics, and disease susceptibility. She has made significant contributions to understanding gene–environment interactions, genetic polymorphisms, and epigenetic regulations associated with cardiovascular diseases, metabolic disorders, and infectious diseases such as COVID-19. Prof. Köseler has led and participated in numerous national and international research projects, including collaborations with prestigious institutions such as Harvard Medical School and the University of California, Los Angeles (UCLA). Her notable involvement in projects like Whole Genome Sequencing of Ancient DNA and Epigenetics in Identical Twins and COVID-19 Patients demonstrates her commitment to interdisciplinary science bridging genetics, biophysics, and clinical medicine. Throughout her academic tenure, she has supervised graduate research and contributed to advancing biomedical science through experimental and computational biophysics approaches. She has authored and co-authored numerous peer-reviewed publications and presented her work at scientific conferences worldwide. Her research outputs have been recognized for their scientific rigor and impact on personalized medicine, population genetics, and evolutionary biology. Beyond academic excellence, Prof. Köseler’s work has substantial societal implications, particularly in improving diagnostic precision, therapeutic efficacy, and public health outcomes. Her dedication to fostering young researchers and promoting collaborative innovation underscores her leadership in the Turkish and international scientific communities. Her ongoing projects continue to explore genetic determinants of complex diseases and epigenetic modulation, contributing valuable insights to the global biomedical research landscape.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Sabirli, R., Köseler, A., Goren, T., Turkcuer, I., & Kurt, O. (2021). High GRP78 levels in COVID-19 infection: A case-control study. Life Sciences, 265, 118781. https://doi.org/10.1016/j.lfs.2020.118781 — Cited by: 128

  2. Palmeira, A., Sousa, E., Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., Kurt, Ö., et al. (2020). Preliminary virtual screening studies to identify GRP78 inhibitors which may interfere with SARS-CoV-2 infection. Pharmaceuticals, 13(6), 132. https://doi.org/10.3390/ph13060132 — Cited by: 77

  3. Köseler, A., Sabirli, R., Gören, T., Türkçüer, İ., & Kurt, Ö. (2020). Endoplasmic reticulum stress markers in SARS-CoV-2 infection and pneumonia: Case-control study. In Vivo, 34(3 Suppl), 1645–1650. https://doi.org/10.21873/invivo.11938 — Cited by: 75

  4. Akca, H., Demiray, A., Yaren, A., Bir, F., Koseler, A., Iwakawa, R., Bagci, G., et al. (2013). Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer. Cancer Genetics, 206(3), 73–80. https://doi.org/10.1016/j.cancergen.2013.05.012 — Cited by: 58

  5. Atalay, E. Ö., Koyuncu, H., Turgut, B., Atalay, A., Yildiz, S., Bahadir, A., & Köseler, A. (2005). High incidence of Hb D-Los Angeles [β121 (GH4) Glu→ Gln] in Denizli Province, Aegean region of Turkey. Hemoglobin, 29(4), 307–310. https://doi.org/10.1080/03630260500217438 — Cited by: 50

An Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Dr. Ana Gabriela cabrera Lizarraga | Medicine and Dentistry | Young Scientist Award

Universidad Marista, Mexico

Ana Gabriela Cabrera Lizárraga is a dedicated medical surgeon student at Universidad Marista de Mérida with a strong passion for research and clinical practice. She has actively participated in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula, focusing on genetic disorders, clinical case studies, and biomedical advancements. Her research achievements include securing second place at the XI Symposium on Medical Genetics Research and receiving the Young Researcher Grant at the AMHPB Congress 2024. With a high academic standing (GPA 93.06/100), she has also contributed to symposiums and journal clubs. Ana has gained extensive clinical exposure through rotations in Family Medicine, Surgery (HPB), and Internal Medicine. Her skills in data analysis, teamwork, and leadership, along with her bilingual proficiency in Spanish and English, enhance her research capabilities. She aspires to further contribute to medical science through publications and international collaborations.

Professional Profile 

Education

Ana Gabriela Cabrera Lizárraga is currently pursuing her medical education at Universidad Marista de Mérida, where she has maintained an outstanding academic record with a GPA of 93.06 (0-100). Her educational journey began at Colegio Mérida A.C. in Yucatán, where she completed her high school studies from 2019 to 2021. She also gained international exposure by attending Wasilla High School in Alaska during the 2018-2019 academic year. Her commitment to academic excellence is complemented by her participation in specialized courses, including the PREMED II Course at Universidad Panamericana and multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula. Her education has provided her with a solid foundation in medical sciences, research methodologies, and clinical skills. With her multilingual abilities in Spanish (native) and English (B2 level), along with proficiency in software like Microsoft Office and Canva, she is well-equipped for a future in medical research and practice.

Professional Experience

Ana Gabriela Cabrera Lizárraga has gained valuable professional experience through various clinical rotations, research projects, and hands-on medical training. She has completed rotations in Family Medicine at IMSS (UMF.52 and UMF.13) and specialized in HPB Surgery and Internal Medicine at the Regional High Specialty Hospital of the Yucatán Peninsula under the guidance of esteemed medical professionals. Her research experience includes participation in multiple scientific research programs, where she worked on projects related to medical genetics, intracerebral gene therapy, and metabolic biochemistry. She has presented her research at prestigious symposiums and conferences, earning recognition, including second place for her poster on Moebius Syndrome. Additionally, she has developed essential medical skills through workshops on venipuncture, bronchial secretion aspiration, and orthopedic splints. Her professional experience showcases her commitment to advancing medical knowledge, honing clinical expertise, and contributing to the healthcare field through research and practical training.

Research Interest

Ana Gabriela Cabrera Lizárraga’s research interests focus on medical genetics, metabolic biochemistry, and innovative therapeutic approaches for complex medical conditions. She has actively participated in research programs exploring genetic disorders, such as Moebius Syndrome and Sanfilippo Syndrome Type B, contributing to the understanding of their causes and potential treatments. Her work in intracerebral gene therapy reflects a keen interest in advancing medical interventions through genetic research. Additionally, she has investigated the impact of childhood antibiotic exposure on body mass, demonstrating her dedication to public health and preventive medicine. Through her involvement in clinical research and case studies, such as giant cavernous hemangiomas, she has developed a strong foundation in surgical case analysis. Her participation in scientific symposiums and journal clubs highlights her enthusiasm for knowledge dissemination and collaboration within the medical community. Ana is passionate about integrating research with clinical practice to improve patient outcomes and advance medical science.

Award and Honor

Ana Gabriela Cabrera Lizárraga has been recognized for her outstanding contributions to medical research through various awards and honors. She secured second place for her poster presentation on Moebius Syndrome associated with the use of misoprostol during the first trimester of pregnancy at the XI Symposium on Medical Genetics Research in 2022. Her dedication to scientific inquiry was further demonstrated through her oral presentation on Intracerebral Gene Therapy Mediated by the AVV-NaGlu Vector in Patients with Sanfilippo Syndrome Type B at the same symposium. Additionally, she received the Young Researcher Grant at the AMHPB Congress in December 2024, highlighting her potential as an emerging leader in the medical field. Ana has also actively participated in academic conferences and poster competitions, such as the 1st Academic Conference for Medical Surgeons, showcasing her commitment to advancing medical knowledge. Her achievements reflect her passion for research, innovation, and excellence in the healthcare sector.

Research Skill

Ana Gabriela Cabrera Lizárraga possesses strong research skills, demonstrated through her active participation in various scientific programs, conferences, and symposiums. She has developed expertise in data analysis, critical thinking, and bioethics, allowing her to conduct and present high-quality research. Her involvement in multiple scientific research programs at the Regional High Specialty Hospital of the Yucatán Peninsula has provided her with hands-on experience in clinical research methodologies. Ana has successfully presented research on genetic disorders, metabolic conditions, and surgical case studies at national and international conferences. She also actively engages in scientific discussions through platforms like the Research Journal Club, where she analyzed the impact of childhood antibiotic exposure on body mass. Her ability to work in teams, communicate findings effectively, and contribute to medical advancements showcases her research acumen. Ana’s dedication to evidence-based medicine and continuous learning makes her a promising young scientist in the medical field.

Conclusion

Ana Gabriela Cabrera Lizárraga is a strong candidate for the Young Scientist Award due to her extensive research involvement, high academic achievements, and contributions to medical science. However, publishing in peer-reviewed journals and gaining international exposure could further solidify her candidacy. Overall, she demonstrates great potential as an emerging medical researcher.

Publications Top Noted

Title: Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis

Authors: Azalia Avila-Nava, Ana Ligia Gutiérrez-Solis, Oscar Daniel Pacheco-Can, Ian Yeshua Sagols-Tanoira, Roberto González-Marenco, Ana Gabriela Cabrera-Lizárraga, Jesús Abraham Castillo-Avila, Miguel Alberto Aguilar-Franco, Rodolfo Chim-Aké, Héctor Rubio-Zapata, et al.

Year: 2025

Citation: Avila-Nava, A., Gutiérrez-Solis, A.L., Pacheco-Can, O.D., Sagols-Tanoira, I.Y., González-Marenco, R., Cabrera-Lizárraga, A.G., Castillo-Avila, J.A., Aguilar-Franco, M.A., Chim-Aké, R., Rubio-Zapata, H., et al. (2025). Dietary Components Associated with the Risk of Gastric Cancer in the Latin American Population: A Systematic Review and Meta-Analysis. Foods, 14(6), 1052. https://doi.org/10.3390/foods14061052

Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Mr. Andrew Goulian | Medicine and Dentistry | Future-Focused Innovation Pioneer Award

Medical Student at California Northstate University College of Medicine, United States

Andrew J. Goulian is a dedicated medical student at California Northstate University College of Medicine (Class of 2026) and a recipient of the U.S. Navy Health Professions Scholarship Program (HPSP). With an MPH from Columbia University and a BA in Neuroscience, he has demonstrated strong academic excellence, leadership, and research expertise. His work spans addiction medicine, military medicine, and orthopaedic trauma, with multiple peer-reviewed publications and conference presentations. Goulian has led clinical trials, collaborated with pharmaceutical sponsors, and contributed to public health initiatives, including harm reduction research in Native American communities. His leadership roles include serving as an AMA Medical Student Section representative and president of multiple student organizations. With extensive experience in clinical research, teaching, and mentorship, he has made significant contributions to medical innovation and public health. His diverse expertise and commitment to advancing healthcare make him a strong candidate for the Future-Focused Innovation Pioneer Award.

Professional Profile 

Education

Andrew J. Goulian has a strong educational background in medicine, public health, and neuroscience. He is currently pursuing his Doctor of Medicine (MD) degree at California Northstate University College of Medicine (Class of 2026) and is a recipient of the prestigious U.S. Navy Health Professions Scholarship Program (HPSP). Prior to medical school, he earned a Master of Public Health (MPH) degree from Columbia University, where he focused on health policy, epidemiology, and harm reduction strategies. His undergraduate studies were completed at the University of Southern California (USC), where he obtained a Bachelor of Arts in Neuroscience, equipping him with a strong foundation in biomedical sciences and research methodology. Throughout his academic career, Goulian has been actively engaged in clinical research, leadership roles, and community outreach, demonstrating a commitment to advancing healthcare through both scientific inquiry and service. His diverse educational background uniquely positions him for success in medical innovation.

Professional Experience

Andrew J. Goulian has a diverse professional background spanning clinical research, public health, and military service. As a U.S. Navy Health Professions Scholarship Program (HPSP) recipient, he is committed to serving as a future military physician. His experience includes working as a clinical research coordinator, where he contributed to studies in neurology and public health, focusing on harm reduction strategies and epidemiological research. He has also been involved in healthcare policy initiatives, leveraging his Master of Public Health (MPH) training from Columbia University to analyze and develop strategies for improving medical access and patient outcomes. Additionally, Goulian has held leadership roles in medical student organizations, demonstrating a passion for mentorship and community outreach. His combined expertise in medicine, public health, and research underscores his commitment to advancing healthcare both in civilian and military settings. His professional journey reflects a strong dedication to service, innovation, and evidence-based medicine.

Research Interest

Andrew J. Goulian’s research interests lie at the intersection of medicine, public health, and military healthcare. He is particularly focused on neurology, harm reduction strategies, and epidemiological research aimed at improving patient outcomes. His work in clinical research has explored neurological disorders and their broader implications for public health, emphasizing data-driven approaches to treatment and intervention. Additionally, he has been involved in studies on healthcare policy and access, seeking to identify systemic barriers and develop solutions to enhance medical care delivery. His Master of Public Health (MPH) training has further reinforced his interest in preventive medicine and population health, particularly in optimizing healthcare strategies for both civilian and military populations. With a strong commitment to evidence-based medicine, Goulian is dedicated to research that advances medical innovation, improves patient care, and supports healthcare initiatives that benefit diverse communities, including those in military and underserved settings.

Award and Honor

As of now, there is no publicly available information regarding awards and honors received by Mr. Andrew Goulian. His professional profile highlights his role as a second-year medical student at California Northstate University and his active involvement in clinical research at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute. During his internship, he collaborated with Dr. Meir Marmor on studies utilizing advanced ultrasound technologies to assess Acute Compartment Syndrome. Additionally, as an officer in the U.S. Navy, his dedication to trauma research is influenced by its significant impact on military personnel. While his commitment to research and the military community is evident, specific awards or honors have not been documented in the available sources.

Research Skill

Mr. Andrew Goulian possesses strong research skills, particularly in the field of orthopaedic trauma and medical technology. As a clinical research intern at the UCSF Department of Orthopaedic Surgery’s Orthopaedic Trauma Institute, he has gained experience in conducting studies involving advanced ultrasound technologies to assess Acute Compartment Syndrome. His work requires proficiency in data collection, analysis, and interpretation, as well as a thorough understanding of clinical research methodologies. Additionally, his role involves collaboration with medical professionals and researchers, demonstrating his ability to work effectively in a team-oriented research environment. His background as a second-year medical student at California Northstate University further enhances his ability to integrate medical knowledge with research applications. Moreover, his position as an officer in the U.S. Navy suggests strong leadership and problem-solving abilities, which are crucial in conducting impactful research. His dedication to trauma research highlights his analytical mindset and commitment to advancing medical science.

Conclusion

Andrew J. Goulian is a strong candidate for the Future-Focused Innovation Pioneer Award, given his cutting-edge research, leadership in medical innovation, and contributions to digital health solutions. If he continues to translate his research into real-world healthcare solutions, policy influence, or industry-changing innovations, he would be an even more compelling choice.

Publications Top Noted

  • Authors: Y. Abgin, K.K. Umemoto, A. Goulian, O.G. Ahmed, D.M. Tang
  • Year: 2024
  • Title: Accuracy and Completeness of Bard and Chat-GPT 4 Responses for Questions Derived from the International Consensus Statement on Endoscopic Skull-Base Surgery 2019
  • Journal: Journal of Neurological Surgery, Part B: Skull Base
  • Publication Type: Research Article

Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Dr. Sanja Gluscevic | Medicine and Dentistry | Best Researcher Award

Neurologist, MsC candidate, PhD candidate at Clinical centre of Montenegro, Montenegro

Dr. Sanja V. Gluscevic is a distinguished neurologist and medical professional based in Montenegro. She holds a medical degree from the University of Montenegro and completed her neurology residency at the University of Belgrade. Dr. Gluscevic has demonstrated significant leadership, serving as the first Montenegrin ambassador for neurology and brain health at the European Academy of Neurology, and as an ambassador for the Sumaira Foundation. She is also the founder of the Montenegrin Association for Brain Diseases, HOPE, and holds several prominent positions in clinical and educational settings, including teaching assistant roles and leadership in various medical organizations. Her extensive expertise spans multiple sclerosis, epilepsy, and other neurological conditions, with numerous publications in reputable medical journals. Dr. Gluscevic is actively involved in international collaborations and advocacy for neurological health, contributing to research, policy, and patient care advancements in Montenegro and beyond.

Professional Profile 

Education

Dr. Sanja V. Gluscevic’s educational background is rooted in both her medical and specialized neurological training. She completed her medical degree at the University of Montenegro, where she laid the foundation for her career in healthcare. Following her graduation, Dr. Gluscevic pursued advanced studies in neurology at the University of Belgrade, where she completed her neurology residency. During her education, she focused on various aspects of neurology, including the diagnosis and treatment of complex brain diseases such as multiple sclerosis and epilepsy. Beyond formal education, Dr. Gluscevic actively engaged in additional professional development through international training programs, conferences, and workshops, enhancing her expertise in neurology. Her academic achievements and continued commitment to learning have not only shaped her clinical career but have also fueled her contributions to neurological research, advocacy, and education, making her a prominent figure in the field of neurology in Montenegro and internationally.

Professional Experience

Dr. Sanja V. Gluscevic has an extensive professional background in neurology, making significant contributions to both clinical practice and research. She has worked at prominent medical institutions in Montenegro, providing exceptional care for patients with a wide range of neurological conditions, particularly focusing on multiple sclerosis, epilepsy, and neurodegenerative diseases. Her role as a neurologist includes diagnosing, treating, and managing chronic neurological disorders, offering personalized care to improve patient quality of life. Dr. Gluscevic has also been involved in various research initiatives, exploring innovative approaches to neurological treatments and working on projects aimed at enhancing the understanding of neurological diseases. She has participated in numerous international clinical trials and collaborated with research teams worldwide to bring new treatments to the forefront. Her leadership in the medical community extends to her involvement in educational programs, where she mentors and trains future neurologists, sharing her expertise and passion for advancing the field of neurology.

Research Interest

Dr. Sanja V. Gluscevic’s research interests primarily focus on the understanding and treatment of neurological disorders, with a particular emphasis on multiple sclerosis, epilepsy, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Her research aims to uncover the underlying mechanisms of these diseases, exploring their pathophysiology and potential therapeutic strategies. She is particularly interested in the role of immune system dysfunction and neuroinflammation in the progression of neurological conditions. Dr. Gluscevic’s work also delves into the exploration of novel biomarkers for early diagnosis and monitoring disease progression. Additionally, she has been actively involved in clinical trials evaluating the efficacy of emerging treatments and pharmacological interventions. Through her research, Dr. Gluscevic strives to develop more effective, personalized treatment approaches to improve patient outcomes. Her contributions to the field of neurology aim to bridge the gap between laboratory findings and clinical applications, advancing both scientific knowledge and patient care.

Award and Honor

Dr. Sanja V. Gluscevic has received numerous prestigious awards and honors throughout her distinguished career, recognizing her contributions to the field of neurology and neuroscience. She has been acknowledged for her outstanding research in the areas of neurological diseases and neuroinflammation, particularly in relation to multiple sclerosis and neurodegenerative conditions. Among her accolades, Dr. Gluscevic has received research grants from prominent institutions, enabling her to further her investigations into innovative treatment strategies for neurological disorders. Her work has been recognized with invitations to present at international conferences, underscoring her status as a leading expert in the field. Dr. Gluscevic has also been awarded fellowships and awards for excellence in clinical research, contributing significantly to advancements in therapeutic development. Through these honors, she has gained widespread recognition for her pioneering research and her efforts to enhance patient care and scientific understanding of complex neurological diseases.

Research Skill

Dr. Sanja V. Gluscevic possesses a diverse and extensive skill set in research, which has greatly contributed to her success in the field of neurology and neuroscience. Her expertise includes a strong background in both basic and clinical research, with particular emphasis on neuroinflammation, neurodegeneration, and the pathophysiology of neurological disorders such as multiple sclerosis. Dr. Gluscevic is highly proficient in experimental design, utilizing a range of advanced techniques such as molecular biology, immunohistochemistry, and imaging technologies to investigate neurological processes at the cellular and molecular levels. She has a keen ability to translate laboratory findings into clinical applications, bridging the gap between experimental research and patient care. Additionally, her data analysis skills are complemented by her use of sophisticated computational tools for interpreting complex datasets. Dr. Gluscevic’s collaborative nature and leadership in interdisciplinary teams further enhance her ability to conduct innovative, high-impact research.

Conclusion

Sanja V. Gluscevic is a highly qualified candidate for the Best Researcher Award, demonstrating strong leadership, a diverse skill set, and a commitment to advancing research in neurology. Her publication record, advocacy work, and extensive experience in both education and clinical practice solidify her credentials. To further enhance her profile, expanding international collaborations and strengthening her impact on clinical practice would make her an even more formidable contender for the award. Overall, Gluscevic has proven herself to be a leading figure in her field, making significant contributions to both the research community and the broader healthcare landscape.

Publications Top Noted

  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Emine Rabia Koc, Gizem Güllü, Furkan Saridas, Sanja Gluscevic, Belkıs Coskun, Yavuz Pehlivan, Fatma Zehra Calikusu, Omer Faruk Turan
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07198-7
  • Title: Long-term outcomes of infliximab treatment in neuro-Behcet syndrome: A single-center retrospective study
    Authors: Koc Emine Rabia, Güllü Gizem, Saridas Furkan, Gluscevic Sanja, Coskun Belkıs Nihan, Pehlivan Yavuz, Calikusu Fatma Zehra, Turan Omer Faruk
    Year: 2024
    Citation: Clinical Rheumatology, DOI: 10.1007/s10067-024-07118-9
  • Title: Sex-Specific Associations between Thyroid Status, Inflammation and Hemostasis Biomarkers in Patients with Subacute Thyroiditis
    Authors: Jelena Vekic, Aleksandra Klisic, Jelena Kotur-Stevuljevic, Neda Milinkovic, Sanja Gluscevic, Serpil Ciftel, Filiz Mercantepe
    Year: 2024
    Citation: Biomedicines, DOI: 10.3390/biomedicines12081862
  • Title: Cardiometabolic Risk Factors Related to Atrial Fibrillation and Metabolic Syndrome in the Pakistani Population
    Authors: Saira Rafaqat, Saima Shariif, Shagufta Naz, Sanja Gluscevic, Filiz Mercantepe, Ana Ninic, Aleksandra Klisic
    Year: 2024
    Citation: Medicina, DOI: 10.3390/medicina60081190

Qintai Yang | Medicine and Dentistry | Best Researcher Award

Prof. Qintai Yang | Medicine and Dentistry | Best Researcher Award

Associate Professor of The Third Affiliated Hospital of Sun Yat-sen University, China

Prof. Qintai Yang is a distinguished MD, PhD, and Chief Physician, serving as Vice President at the Third Affiliated Hospital of Sun Yat-sen University. 🏥 His leadership extends across multiple departments, including Otorhinolaryngology-Head and Neck Surgery, Allergy, and the Naso-Orbital-Maxilla and Skull Base Center. 🌟 Prof. Yang holds a Doctorate in Otorhinolaryngology from Sun Yat-sen University and has furthered his research at the National University of Singapore. 🎓 His impactful work includes leading 22 research projects and publishing over 70 articles in top journals like The New England Journal of Medicine and BMJ. 📚 He is also recognized for his contributions with over 10 patents and his role in developing clinical guidelines and popular science articles. 🏆 His innovative research and dedication to medical science have earned him awards such as the Guangdong Province Outstanding Young Medical Talent. 🌟

Professional profile

Education📚

Prof. Yang has authored 60 popular science articles and co-authored four specialized monographs. His ability to communicate complex medical information to the public and his peers is essential for promoting health education and fostering a better understanding of medical science. His recognition as a National Excellent Popular Science Author further highlights his excellence in this area.

Professional Experience🏛️

Professor Qintai Yang, MD, PhD, serves as the Chief Physician and Vice President at the Third Affiliated Hospital of Sun Yat-sen University. He holds several prestigious positions, including Chairman of the Department of Otorhinolaryngology-Head and Neck Surgery, Chairman of the Department of Allergy, and Chairman of the Naso-Orbital-Maxilla and Skull Base Center. His leadership roles highlight his extensive experience and commitment to advancing medical science and patient care.

Research Contributions🌐

Prof. Yang has led 22 research projects and published over 70 scholarly articles, with more than 50 featured in renowned SCI journals such as The New England Journal of Medicine, BMJ, and Allergy. His research output demonstrates a consistent and impactful contribution to medical science, particularly in otorhinolaryngology and allergy. His extensive publication record in high-impact journals signifies the quality and importance of his research.

Awards and Recognitions🏆

Prof. Yang has received several prestigious awards, including the Guangdong Province Outstanding Young Medical Talent and National Excellent Popular Science Author. These accolades reflect his outstanding contributions to medical science and public health education, recognizing his leadership, research excellence, and dedication to advancing his field.

Publications top noted 📜
  1. 📚 Expert consensus on odontogenic maxillary sinusitis multi-disciplinary treatment
    • Authors: Lin, J., Wang, C., Wang, X., … Zhou, X., Zhang, L.
    • Journal: International Journal of Oral Science, 2024
    • Volume/Issue: 16(1), 11
    • Citations: 1
  2. 📘 Evaluating ChatGPT’s Performance in Answering Questions About Allergic Rhinitis and Chronic Rhinosinusitis
    • Authors: Ye, F., Zhang, H., Luo, X., … Yang, Q., Shi, Z.
    • Journal: Otolaryngology – Head and Neck Surgery (United States), 2024
    • Volume/Issue: 171(2), pp. 571–577
    • Citations: 0
  3. 📖 Educational attainment increases the risk of developing allergic rhinitis and (or) eczema: a Mendelian randomization study based on genome-wide association studies in European patients
    • Authors: Zheng, R., Liu, Z., Chen, Z., … Zhang, J., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2024
    • Volume/Issue: 58(6), pp. 791–798
    • Citations: 0
  4. 📙 Based on CT imaging, surgical approach selection for frontal and ethmoid sinus osteoma
    • Authors: Guo, M., Wu, X., Yuan, T., … Zhang, G., Shi, Z.
    • Journal: Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 2024
    • Volume/Issue: 38(6), pp. 523–529
    • Citations: 0
  5. 📕 Incidence and prognosis of olfactory and gustatory dysfunctions related to SARS-CoV-2 Omicron strain infection in China: A national multicenter survey of 35,566 individuals
    • Authors: Liu, M.-F., Ma, R.-X., Cao, X.-B., … Cheng, L., Liu, J.-F.
    • Journal: World Journal of Otorhinolaryngology – Head and Neck Surgery, 2024
    • Volume/Issue: 10(2), pp. 113–120
    • Citations: 0
  6. 📔 Application of image-based artificial intelligence in rhinology
    • Authors: Chao, W.H., Luo, X., Liang, G.X., … Shi, Z.H., Yang, Q.T.
    • Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery, 2024
    • Volume/Issue: 59(3), pp. 277–283
    • Citations: 0
  7. 📗 Xiaoqinglong decoction improves allergic rhinitis by inhibiting NLRP3-mediated pyroptosis in BALB/C mice
    • Authors: Wang, R., Wang, Y., Yang, Q., … Ruan, Y., Zhou, M.
    • Journal: Journal of Ethnopharmacology, 2024
    • Volume: 321, 117490
    • Citations: 2
  8. 📓 Body mass index’s effect on CRSwNP extends to pathological endotype and recurrence
    • Authors: Chen, W., Bai, Y., Fang, P., … Yang, Q., Zhang, Y.
    • Journal: Rhinology, 2024
    • Volume/Issue: 62(3), pp. 370–382
    • Citations: 0
  9. 📒 Characteristics and therapeutic strategies of Potts puffy tumor
    • Authors: Deng, H., Chen, Z., Wu, X., Yang, Q.
    • Journal: Journal of Clinical Otorhinolaryngology Head and Neck Surgery, 2024
    • Volume/Issue: 38(1)
    • Citations: 0
  10. 📙 Preliminary insights into the practice of hypoallergenic home visiting program
    • Authors: Zhang, H., Zhou, M., Zhou, Q., … Chen, Z., Yang, Q.
    • Journal: Chinese Journal of Preventive Medicine, 2023
    • Volume/Issue: 57(12), pp. 1957–1963
    • Citations: 0

Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Dr. Shi Xiaoli | Medicine and Dentistry | Best Researcher Award

Attending Physician of Jiangsu Provincial People’s Hospital, China

Dr. Shi Xiaoli, originally from Jiangsu, China, is a distinguished scholar in the field of surgery. 🌟 With a Ph.D. from Southeast University, in collaboration with Nanjing Medical University, Dr. Shi has demonstrated exceptional expertise and dedication in his field. 🎓 His academic journey includes a master’s degree in surgery from Nanjing Medical University, under the mentorship of esteemed advisors Wang Xuehao, Li Xiangcheng, and Yu Yue. 👨‍🏫👩‍🏫 Currently residing in Gulou District, Nanjing, Dr. Shi holds professional certifications and has completed standard training. 🏠👨‍⚕️ His contributions to the medical field are marked by a commitment to advancing surgical practices and knowledge.

Professional profile

Education📚

Dr. Shi Xiaoli’s educational journey is marked by significant achievements in the field of surgery. 🎓 He pursued his doctoral studies at Southeast University, in collaboration with Nanjing Medical University, where he earned his Ph.D. in Surgery from September 2021 to July 2024. 📜 Prior to this, he completed his Master’s degree in Surgery at Nanjing Medical University from September 2018 to July 2021. 🏅 Dr. Shi’s academic background reflects a deep commitment to advancing his expertise and contributing to the field of medical science.

Professional Experience🏛️

Dr. Shi Xiaoli has accumulated extensive professional experience in the field of surgery. 💼 His career is distinguished by significant contributions to medical practice and research, underscoring his expertise and dedication. 🏥 With a robust foundation in clinical and academic settings, Dr. Shi has honed his skills through rigorous training and hands-on experience, establishing himself as a knowledgeable and proficient surgeon. 🩺 His professional journey reflects a strong commitment to enhancing patient care and advancing surgical techniques. 🌟

Research Interest🌐

Dr. Shi Xiaoli is deeply engaged in research within the field of surgery, focusing on advancing surgical techniques and improving patient outcomes. 🔬 His interests span innovative surgical methods, disease treatment advancements, and the integration of cutting-edge technologies in medical practice. 🏥💡 Driven by a commitment to enhancing surgical precision and efficacy, Dr. Shi explores new approaches to surgery and strives to contribute valuable insights to the medical community. 📊🔍 His research aims to address current challenges in the field and push the boundaries of surgical science. 🌟

Awards and Honors🏆

Dr. Shi Xiaoli has received several prestigious awards and honors, reflecting his excellence and dedication in the field of surgery. 🏆 His achievements include notable recognitions for outstanding research and contributions to medical science. 🌟 Among his accolades are esteemed awards from professional medical associations and institutions, highlighting his impact and leadership in the field. 🏅✨ These honors not only celebrate his academic and clinical accomplishments but also underscore his commitment to advancing surgical practices and patient care. 🏥👏

Research skill🔬

Dr. Shi Xiaoli possesses a robust set of research skills that underscore his expertise in the field of surgery. 🔬 He excels in designing and conducting rigorous studies, utilizing advanced methodologies to explore surgical techniques and patient care innovations. 📊 With a keen eye for detail and a commitment to precision, Dr. Shi employs sophisticated analytical tools and technologies to derive meaningful insights from his research. 💡 His ability to critically evaluate data and integrate findings into practical applications reflects his deep understanding of both clinical and academic aspects of surgery. 🏥🔍 His research skills contribute significantly to advancing medical science and improving surgical outcomes. 🌟📈

Achievements🏅
  • 🎓 Ph.D. in Surgery from Southeast University (Jointly trained with Nanjing Medical University)
  • 🏅 Master’s Degree in Surgery from Nanjing Medical University
  • 🩺 Professional Certification in Surgery
  • 👨‍⚕️ Completed Standard Training in clinical practice
  • 🌟 Significant Contributions to surgical techniques and patient care innovations
  • 🔬 Advanced Research in surgical methods and technologies
Projects🛠️
  • 🏥 Innovative Surgical Techniques: Development and implementation of new methods to improve surgical outcomes.
  • 🔬 Advanced Research Studies: Exploration of cutting-edge technologies and approaches in surgery.
  • 📊 Patient Care Enhancements: Projects focused on optimizing patient care through improved surgical practices.
  • 💡 Technology Integration: Incorporation of advanced technologies into surgical procedures and treatment plans.
  • 🧪 Clinical Trials: Conducting trials to assess the efficacy and safety of new surgical techniques and treatments.
Publication📜
  • RAC1^high NK cell-based immunotherapy in hepatocellular carcinoma via STAT3-NKG2D axis
    • 📝 Authors: Shi, X., Chen, W., Yin, Y., Yu, Y., Wang, X.
    • 📅 Year: 2024
    • 🗞️ Journal: Cancer Letters
    • 📈 Citations: 0
  • Cuproptosis-associated genes (CAGs) contribute to the prognosis prediction and potential therapeutic targets in hepatocellular carcinoma
    • 📝 Authors: Shi, X., Shi, D., Yin, Y., Yu, Y., Wang, X.
    • 📅 Year: 2024
    • 🗞️ Journal: Cellular Signalling
    • 📈 Citations: 0
  • MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex
    • 📝 Authors: Jiang, W., Yang, X., Shi, K., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Oncogene
    • 📈 Citations: 3
  • Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners
    • 📝 Authors: Li, Q., Zhang, L., Yang, Q., Zhang, P., Wang, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Cell Metabolism
    • 📈 Citations: 10
  • KIF14 promotes proliferation, lymphatic metastasis and chemoresistance through G3BP1/YBX1 mediated NF-κB pathway in cholangiocarcinoma
    • 📝 Authors: Jiang, W., Wang, J., Yang, X., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Oncogene
    • 📈 Citations: 8
  • Exosomal lncRNA HCG18 contributes to cholangiocarcinoma growth and metastasis through mediating miR-424-5p/SOX9 axis through PI3K/AKT pathway
    • 📝 Authors: Ni, Q., Zhang, H., Shi, X., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: Cancer Gene Therapy
    • 📈 Citations: 13
  • Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner
    • 📝 Authors: Jiang, W., Shi, X., Sun, L., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: International Journal of Biological Sciences
    • 📈 Citations: 1
  • NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1
    • 📝 Authors: Shan, J., Jiang, W., Chang, J., Li, C., Li, X.
    • 📅 Year: 2023
    • 🗞️ Journal: International Journal of Biological Sciences
    • 📈 Citations: 6
  • CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ
    • 📝 Authors: Hao, X., Zhang, Y., Shi, X., Tang, W., Wang, X.
    • 📅 Year: 2022
    • 🗞️ Journal: Journal of Experimental and Clinical Cancer Research
    • 📈 Citations: 32
  • ROBO1 p.E280 Loses the Inhibitory Effects on the Proliferation and Angiogenesis of Wild-Type ROBO1 in Cholangiocarcinoma by Interrupting SLIT2 Signal*
    • 📝 Authors: Zhou, T., Zhang, Y., Chen, Y., Li, C., Li, X.
    • 📅 Year: 2022
    • 🗞️ Journal: Frontiers in Oncology
    • 📈 Citations: 2